Public COA audit

Ipamorelin

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
83%
Panels
3/7
Purity (printed)
99.8%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-IPA10-2603-1
Identity method
FTIR (USP <197A>)
Sample date
2026-04-02
Issue date
2026-04-05

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    FTIR sample spectrum confirms the presence of Ipamorelin with addition of excipient(s)/fillers

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.8%

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    18.7 EU/vial (limit 40 EU/vial)

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity

    99.8% purity is excellent and normal for research-grade peptides

  • FTIR confirmation

    Identity confirmed via FTIR spectroscopy with characteristic peptide bands; excipients noted

  • Potency below specification

    HPLC potency assay shows 59.6%, 90.7%, and 88.5% of labeled 10 mg across three measurements; two of three fall below the 90-110% specification range

  • Batch number present

    Lot CR-IPA10-2603-1 clearly documented

  • Dates within normal range

    Sample tested 4/2/2026, report issued 4/5/2026, endotoxin test 4/8/2026 with report 4/10/2026; all dates are reasonable and sequential

  • Lab information complete

    BTLabs, West Palm Beach FL, with contact details and website provided

  • Endotoxin testing performed

    Separate endotoxin COA (report IF-824-QSA-TR006-BTL26130-24) shows passing result at 18.7 EU/vial

  • Professional presentation

    Document includes FTIR spectrum, HPLC chromatogram, QR code, signatures, and detailed methodology references

  • Limited testing scope

    No heavy metals, microbial contamination, sterility, or residual solvent testing; document explicitly states it does not provide information on particulate matter or microbial contamination

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.